skip to Main Content
design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

San Diego/Tijuana Is Finalist To Become A World Design Capital

San Diego/Tijuana is finalist to become a World Design Capital

San Diego Union Tribune

The San Diego/Tijuana region is a finalist to become a World Design Capital that could mean a year-long promotion of the binational region.

Winners are chosen based on how each region effectively incorporates design across their economic, technological, social, cultural, political and environmental sectors . More than just having a fancy title, winning means a year of events to promote the region, including a street festival, a one-day celebration highlighting the winner’s designs and a design conference that should bring people from around the globe.

“This is an incredibly exciting opportunity to not only showcase our bi-national region as a longstanding design and innovation powerhouse,” she wrote, “but to also shape the narrative around what it means to be a 21st century metropolis, [says Michèle Morris, President of the Design Forward Alliance and Associate Director of UCSD Design Lab]."
Cancer Care Kentucky Design Lab Ucsd

Experiencing Cancer in Appalachian Kentucky

A new paper from The Design Lab's Melanie McComsey and Eliah Aronoff-Spencer describes a new framework for improving #cancer care in Appalachian Kentucky. The project would leverage broadband connectivity and cancer communication research to make a difference in the lives of patients and their families.

Nothing tells the story of people working together better than a community quilt. A diversity of talents, colors, and materials brought together through skill and shared purpose. Perhaps never before have we as Americans needed a stronger reminder that many hands make short work of big problems. The work presented here by the L.A.U.N.C.H. Collaborative offers a new framework for health care that could be compared to a digital quilt, powered by community-based participatory design, with lived expertise and the newest advances in broadband-enabled connected health solutions. This work demonstrates the value and need to engage local communities and what can be learned when beneficiaries and traditional caregivers work together to develop healthcare solutions.
San Diego Design Week Scripps

San Diego Design Week Celebrates Creativity and Innovation

"Everyone is a designer ... Design is a way of thinking — a way to change things for good."
Don Norman reflects on the evolution and future of design in San Diego in this San Diego Union-Tribune article. San Diego's first Design Week, a milestone event, happened from Sept. 9-13.

(Courtesy photo by Darren Bradley)
San Diego -- Tijuana

Can San Diego — Tijuana region be World Design Capital?

Read the San Diego Union Tribune article by columnist Diane Bell about the World Design Capital bid.

San Diego, together with Tijuana, has placed a bid to be designated the 2024 World Design Capital , a selection that will be finalized this October.

A San Diego nonprofit called the Design Forward Alliance was created with the help of numerous community and design groups to coordinate with Tijuana representatives and prepare the bid package.

Michèle Morris, associate director of the UCSD Design Lab and president of the Design Forward Alliance, is very optimistic about this region’s chances for success.

“We do feel confident that we will make the short list,” she says. Morris also is associate director of the Design Lab at UC San Diego, which helped launch the alliance in 2016 following an inaugural Design Forward Summit in downtown San Diego.

Win or lose, Morris notes that the bidding process has strengthened ties and fostered new creative ideas for our region.
Productivity

Bringing Order to Chaos: How to Increase Productivity By Mastering Unstructured Time

Podcast with Design Lab member Amy Fox

In this episode we will talk to UCSD Cognitive Scientist, Amy Fox, about Structured and Unstructured time. Join us as we learn about the difference between the two, and tips and tricks that can help you organize and boost your productivity.

Triton Tools & Tidbits is a podcast that is focused on discussing topics that will engage and enrich student life and education. Brought to you by the Office of the Vice Chancellor for Student Affairs.
Don-Norman

What is the Future of Design in 50 Seconds?

From Jnd.org & Don Norman: I'm developing a new talk: "21st Century Design: Addressing Major Societal…

Back To Top